ConductScience.org, home

Paper36938678

LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis.

Zhang C and 5 others. Technol Cancer Res Treat, 2023. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis. Papers, record 36938678. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36938678

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis.
PubMed
Journal
Technol Cancer Res Treat
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
2.54
iCite
Revised in PubMed
2023-04-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang CChuanqiang
2Xu LLiang
3Li XXiaowei
4Chen YYueqiu
5Shi TTongguo
6Wang QQiang

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
FerroptosisMajor topic
MicroRNAsMajor topic
RNA, Long NoncodingMajor topic
Female
Humans
Cell Line, Tumor
Cell Proliferation
Gene Expression Regulation, Neoplastic
Myelin and Lymphocyte-Associated Proteolipid Proteins
Up-Regulation

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128428107Clinicopathological factors associated with survival in patients with breast cancer brain metastasis.Hum Pathol2017https://conductscience.org/library/papers/28428107PubMed
233526059LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/33526059PubMed
331786194Mechanisms of lncRNA/microRNA interactions in angiogenesis.Life Sci2020https://conductscience.org/library/papers/31786194PubMed
431364108Downregulated LINC00460 inhibits cell proliferation and promotes cell apoptosis in prostate cancer.Eur Rev Med Pharmacol Sci2019https://conductscience.org/library/papers/31364108PubMed
533251049LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer.Mol Ther Nucleic Acids2020https://conductscience.org/library/papers/33251049PubMed
626609479MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A.Am J Cancer Res2015https://conductscience.org/library/papers/26609479PubMed
732548873lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway.J Cell Mol Med2020https://conductscience.org/library/papers/32548873PubMed
834218256A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer.Cell Death Dis2021https://conductscience.org/library/papers/34218256PubMed
934429409Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer.Nat Commun2021https://conductscience.org/library/papers/34429409PubMed
1032059473MAL2-Induced Actin-Based Protrusion Formation is Anti-Oncogenic in Hepatocellular Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/32059473PubMed
1132633366LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539.Eur Rev Med Pharmacol Sci2020https://conductscience.org/library/papers/32633366PubMed
1235405312Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.Mol Ther2022https://conductscience.org/library/papers/35405312PubMed
1334445129The Role of lncRNA in the Development of Tumors, including Breast Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/34445129PubMed
1433271455FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells.Redox Biol2021https://conductscience.org/library/papers/33271455PubMed
1523879588Cellular iron metabolism in prognosis and therapy of breast cancer.Crit Rev Oncog2013https://conductscience.org/library/papers/23879588PubMed
1625736597MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ.Sci Rep2015https://conductscience.org/library/papers/25736597PubMed
1733472555lncRNA LINC00460 Functions as a Competing Endogenous RNA and Regulates Expression of BGN by Sponging miR-149-5p in Colorectal Cancer.Technol Cancer Res Treat2021https://conductscience.org/library/papers/33472555PubMed
1830195491MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines.Biochem Biophys Res Commun2018https://conductscience.org/library/papers/30195491PubMed
1932990678MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.J Clin Invest2021https://conductscience.org/library/papers/32990678PubMed
2034821482LncRNA LINC00460: Function and mechanism in human cancer.Thorac Cancer2022https://conductscience.org/library/papers/34821482PubMed

See all 39 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42663506Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.Breast J2026https://conductscience.org/library/papers/42663506PubMed
42630874LINC00460 drives clear cell renal cell carcinoma progression via complement/coagulation and p53 pathways: a potential therapeutic target.Am J Transl Res2026https://conductscience.org/library/papers/42630874PubMed
42425938LINC01929 promotes breast cancer progression through a TFRC-associated ferroptosis pathway.Cell Death Discov2026https://conductscience.org/library/papers/42425938PubMed
41868675Epigenetic modifications in ferroptosis regulation of breast cancer.Am J Cancer Res2026https://conductscience.org/library/papers/41868675PubMed
41764215miR-320a enhances radiosensitivity in non-small cell lung cancer by targeting RAD51 and modulating ferroptosis via GPX4.Sci Rep2026https://conductscience.org/library/papers/41764215PubMed
41137040Long non-coding RNAs: key orchestrators of macrophage polarization in breast cancer.Cancer Cell Int2025https://conductscience.org/library/papers/41137040PubMed
41053050Targeting the redox-programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance.Cell Death Discov2025https://conductscience.org/library/papers/41053050PubMed
40887542Ferroptosis and non-coding RNAs in breast cancer: insights into CAF and TAM interactions.Discov Oncol2025https://conductscience.org/library/papers/40887542PubMed
40739681The Vital Role of Long Non-coding RNA SUMO1P3 in the Regulation of Human Cancer: Current Perspectives and Future Challenges.Curr Top Med Chem2026https://conductscience.org/library/papers/40739681PubMed
40176338Exploring Long Noncoding RNAs as Regulators of Tumor Ferroptosis: Advances and Challenges.Cancer Sci2025https://conductscience.org/library/papers/40176338PubMed
39763590The impact of ferroptosis and ferroptosis-related non-coding RNAs on breast cancer progression.Front Cell Dev Biol2024https://conductscience.org/library/papers/39763590PubMed
39759512The modulation of immune cell death in connection to microRNAs and natural products.Front Immunol2024https://conductscience.org/library/papers/39759512PubMed
39242964Non-coding transcriptome profiles in clear-cell renal cell carcinoma.Nat Rev Urol2025https://conductscience.org/library/papers/39242964PubMed
39022677Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications.Noncoding RNA Res2024https://conductscience.org/library/papers/39022677PubMed
38833042METTL3-modified lncRNA DSCAM-AS1 promotes breast cancer progression through inhibiting ferroptosis.J Bioenerg Biomembr2024https://conductscience.org/library/papers/38833042PubMed
38362940Research advances of MAL family members in tumorigenesis and tumor progression (Review).Mol Med Rep2024https://conductscience.org/library/papers/38362940PubMed
37920209Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential.Front Pharmacol2023https://conductscience.org/library/papers/37920209PubMed
37888204The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision.Noncoding RNA2023https://conductscience.org/library/papers/37888204PubMed
37686142The Regulation of Ferroptosis by Noncoding RNAs.Int J Mol Sci2023https://conductscience.org/library/papers/37686142PubMed
37345137The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers.Cancers (Basel)2023https://conductscience.org/library/papers/37345137PubMed

Download CSV of cited by

Genes30

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ARPP1910776PubTator's text mininghttps://conductscience.org/library/genes/10776NCBI Gene
BGN633PubTator's text mininghttps://conductscience.org/library/genes/633NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
ESRRG2104PubTator's text mininghttps://conductscience.org/library/genes/2104NCBI Gene
FBXW755294PubTator's text mininghttps://conductscience.org/library/genes/55294NCBI Gene
FGF72252PubTator's text mininghttps://conductscience.org/library/genes/2252NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
HOTAIR100124700PubTator's text mininghttps://conductscience.org/library/genes/100124700NCBI Gene
IL1929949PubTator's text mininghttps://conductscience.org/library/genes/29949NCBI Gene
IQGAP18826PubTator's text mininghttps://conductscience.org/library/genes/8826NCBI Gene
LINC00460728192PubTator's text mininghttps://conductscience.org/library/genes/728192NCBI Gene
MAL4118PubTator's text mininghttps://conductscience.org/library/genes/4118NCBI Gene
MAL2114569PubTator's text mininghttps://conductscience.org/library/genes/114569NCBI Gene
MIR149406941PubTator's text mininghttps://conductscience.org/library/genes/406941NCBI Gene
MIR320A407037PubTator's text mininghttps://conductscience.org/library/genes/407037NCBI Gene
MIR485574436PubTator's text mininghttps://conductscience.org/library/genes/574436NCBI Gene
MIR489574442PubTator's text mininghttps://conductscience.org/library/genes/574442NCBI Gene

See all 30 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36938678

GET https://conductscience.org/api/papers/v1/36938678/references?page=2